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The L2 protein of the human papillomaviruses is a minor structural protein and is not necessary for the major L1 protein
to assemble into capsids. However L2 protein binds DNA and enhances the efficiency of HPV capsid assembly, suggesting
an important role in the production of infectious papillomaviruses. L2 accumulates rapidly in the nucleus after synthesis in
the cytoplasm. To identify L2 sequences responsible for nuclear targeting and accumulation, full-length HPV6bL2 protein
and L2 proteins containing sequence deletions were expressed in CV-1 cells, using recombinant vaccinia viruses. bgal
protein fused to C-terminal and N-terminal L2 sequences were localized in the nucleus and demonstrated that both the C-
terminal putative nuclear localization signal (NLS) and N-terminal DNA binding sequences of the L2 protein, which are rich
in arginine and lysine, are functional in targeting proteins into the nucleus. L2 mutants lacking amino acids (aa 286–306)
do not accumulate in nucleus even when the C-terminal NLS and N-terminal DNA binding sequences are intact. Accumulation
in the nucleus of L2 protein lacking aa 286–306 could be also achieved by increasing the L2 protein size via insertion of
a portion of L1 protein. Amino acid sequence alignment of L2 proteins from sequenced papillomaviruses showed that
sequences in this region are relatively conserved. Our results indicate that in the L2 protein, the nuclear targeting and
accumulation are controlled by two different sequences and the rapid nuclear translocation and accumulation may play an
important role in papillomavirus life cycle. q 1995 Academic Press, Inc.
INTRODUCTION and another protein Ran/TC4 and ATP are required for
active translocation (Gorlich et al., 1994).
Papillomaviruses are members of the papovavirus
The N-terminal and C-terminal amino acids of the pap-
family. The structural proteins of the virus include the
illomavirus L2 proteins contain a basic stretch (Zhou et
capsid proteins L1 and L2, as well as host-contributed
al., 1991b, 1994), which was hypothesized to be responsi-
histones/DNA complex (Favre et al., 1975; Pfister et al.,
ble for DNA binding (Zhou et al., 1994), and transport of
1977). The capsid proteins are synthesized in the cyto-
newly synthesized L2 into the nucleus (Zhou et al.,
plasm of infected cells during the late phase of infection
1991b), respectively. Using recombinant vaccinia viruses
and then transported to the nucleus for assembly into
(rVV), we now confirm that the NLS sequence in the L2
infectious particles. A nuclear localization signal (NLS)
C-terminus and DNA binding domain in the N-terminal
has been identified within the C-terminal sequence of
end are functional in directing L2 nuclear transport and
HPV16 L1 protein (Zhou et al., 1991b). The NLS of the
define a further region of the L2 protein which may be
SV40 large T antigen represents the prototypic NLS and
necessary for accumulation of L2 in the nucleus.
is composed of a highly basic, contiguous amino acid
stretch (Lanford and Butel, 1984; Kalderon et al., 1984a,b).
MATERIALS AND METHODSUnlike the motif found in the SV40 large T antigen, some
NLS, such as those found in nucleoplasmin are bipartite
DNA cloningin nature (Robbins et al., 1991). The L1 protein of HPV16
has both types of NLS and both are functional in L1 A gene encoding for wild-type HPV6b L2 was derived
nuclear transportation (Zhou et al., 1991b). The molecular by polymerase chain reaction (PCR) from pHPV6b. The
mechanism for the transport of proteins from the cyto- 1.4-kb HPV6bL2 gene was cloned into the BamHI site of
plasm to the nucleus is still poorly understood, but it has pUC18 to create p4b/6bL2. This construct was used as a
became apparent that protein transport through nuclear template for creating truncated L2 genes by PCR. Primers
pores is a two-step process for which a cytosol protein were designed to generate a set of truncated L2 genes,
named importin is involved in nuclear membrane binding each lacking sequence coding for 40 aa, and with the
deletion frame shifted by 20 aa from the neighboring
members of the set (see Fig. 2). Clones D1–60, D446–1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (708) 216-1196. 459, and D1–60/446–459 were similarly generated by
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PCR amplification with appropriate primers. Primers
were constructed with Bgl II sites in both ends to facilitate
subsequent manipulations. The amplified fragments
were purified by agarose gel electrophoresis and di-
gested with Bgl II. After religation, each construct was
examined by agarose gel electrophoresis to confirm the
expected deletion. The truncated L2 sequences were
cleaved from the parent p4b plasmid and cloned into
pSX3 for construction of rVV (Zhou et al., 1991a,c). The
resulting plasmids were named according to the amino
acids deleted (see Fig. 2, where the D signs are not
listed). For construction of rVV expressing HPV16L1/6L2
hybrid protein, the partial HPV16 L1 gene encoding aa
FIG. 1. Purification of recombinant HPV6b protein. Hexahis-HPV6b191–506 was amplified by PCR and cleaved with BamHI
L1 and L2 fusion proteins were purified as described under Materialsenzyme. The L1 fragment was then cloned into Bgl II site
and Methods, subjected to SDS–PAGE and stained with Coomassieof D286–326 to produce D286–326/L1.
blue. Lane 1, hexahis HPV6bL1 protein. Lane 2, hexahis HPV6bL2
Part of the L2 sequence was fused to the LacZ gene, protein.
and used to produce a rVV. Oligonucleotides encoding
the 6L2 aa 286–306 (IASRRGLVRFSRIGQRGSMH), aa
444–449 (RKRRKR), and aa 5–11 (RARRRKR) were Indirect immunofluorescence
cloned into the 5* of LacZ gene in a vaccinia expression
CV-1 cells grown on multiple chamber slides were
vector pRKbgal in which a LacZ gene was cloned into
infected with HPV6b L2 rVV. Cells were fixed with cold
SmaI site of pRK19 (Zhou et al., 1994). The resultant plas-
ethanol 48 hr postinfection and exposed for 1 hr to 1:2000
mids were named as p6L2(286–306)bgal, p6L2NLS/
diluted polyclonal anti-L2 antibody for L2 recombinant
bgal, and p6L2DNABS/bgal, respectively. The plasmids
vaccinia viruses (Fig. 3) and to 1:200 diluted anti-bgal
were used to construct rVVs as described (Zhou et al.,
monoclonal antibody Gal-13 (Sigma) for bgal proteins
1990) and the diagram of recombinant proteins ex-
fused to HPV6L2 peptides (Fig. 4). At these dilutions, the
pressed by the rVVs are shown in the lower panel of
antisera showed high specificity (Figs. 3A and 4A). After
Fig. 2.
washing with phosphate-buffered saline (PBS) the slides
were incubated with FITC-conjugated anti-rabbit immu-Generating antisera
noglobulin (Sigma) for L2 detection and FITC-linked anti-
The pTRCHis-C vector (Invitrogen) was digested with
mouse IgG (Sigma) for bgal detection. After extensive
EcoRI, treated with Klenow and further digested with
washing, immunofluorescence was evaluated using a
BamHI. The HPV6b L2 gene was amplified by PCR using
Nikon Microphoto-FX fluorescence microscope.
appropriate primers and the amplified fragment was di-
gested with BamHI and SmaI, purified, and cloned into
RESULTS
the digested pTRCHis-C to generate pTRCHis/6L2, in
which L2 was encoded as a Hexahis fusion protein. As papillomaviruses cannot propagate readily in tissue
culture and L2 protein accounts for only 10% of the totalEscherichia coli DH5a cells harboring the HPV6bL2 con-
struct were cultured at 377 and protein expression was capsid protein (Doorbar and Gallimore, 1987), it was
proven difficult to isolate sufficient quantities of the L2induced by the addition of isopropyl-b-D-thiogalactopy-
ranoside (IPTG). Cell lysates were prepared in 6 M urea protein from papillomavirus virions for biochemical and
molecular characterization. To obtain large quantities ofand the insoluble fraction was removed by centrifugation.
L2 protein was purified by affinity Ni2/ column according L2, we have cloned and expressed HPV6BL2 ORF in both
prokaryotic and eukaryotic systems. L2 protein ex-to the manufacturer’s instructions. Briefly, the L2 protein
bound to the Ni2/ charged resin was washed with higher pressed in E. coli was purified by affinity column and
used to generate specific antisera for immunofluores-pH buffers containing 6 M urea. The protein was then
eluted at a low pH. After dialysis to remove urea, the cence studies. Deletion mutants of L2 were expressed
in CV-1 cells by recombinant vaccinia viruses and thepurified L2 protein was examined by 10% sodium dode-
cylsulfate–polyacrylamide gel electrophoresis (SDS – intracellular distribution of L2 and of the deletion mutants
was examined by immunofluorescence staining.PAGE) and Coomassie blue staining (Fig. 1). Polyclonal
antiserum specific for the HPV6b L2 protein was pre- CV-1 cells were infected with rVV expressing individ-
ual deletion mutants of HPV6bL2. At 48 hr after infection,pared by repeated inoculation of 100 mg purified HPV6b
L2 protein, emulsified with Freunds adjuvant, into a rab- the intracellular location of the wild-type and truncated L2
proteins was examined by indirect immunofluorescencebit. Sera were tested for L2 reactivity and specificity by
immunoblot and indirect immunofluorescence. (Fig. 3). CV-1 cells infected with rVV encoding wild-type
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HPV6bL2 protein, and stained with an L2-specific poly- (286IASRRGLVRFSRIGQRGSMH306) was cloned into the
bgal gene and the distribution of this hybrid protein ex-clonal antibody, demonstrated strong nuclear fluores-
cence in all cells positive for L2 (Fig. 3(B1)). To establish pressed by rVV virus was examined by immunofluores-
cence using an anti-bgal monoclonal antibody. Mostwhether the C-terminus of the L2 protein, which contains
a basic sequence between aa 444 and 449 (RKRRKR), cells expressing the L2(286–306)/bgal protein exhibited
a cytoplasmic bgal staining pattern (Figs. 4C and 4D),similar to the classic NLS (Lanford et al., 1986; Lanford
and Butel, 1984), and the N-terminus of L2 protein, which suggesting that aa 286–306 of HPV6bL2 are insufficient
to promote nuclear transport of a protein.is rich in arginines capable of DNA binding (Zhou et al.,
1994), can function as NLS sequences, oligonucleotides From the above results, it is reasonable to conclude
that both the N-terminal DNA binding site and C-terminalencoding the L2 C-terminus sequence and N-terminal
DNA binding sequence (DNABS) were cloned into the 5* NLS sequence of HPV6b L2 are functional in protein
nuclear transportation and contributes to the L2 translo-sequence of beta-galactosidase (bgal) gene. Recombi-
nant VVs encoding these hybrid genes (6L2NLS/bgal cation into the nucleus. L2 is a relatively small protein
(with a predicted Mr of about 50 kDa) and should there-and 6L2DNABS/bgal) were constructed and used to ex-
amine the intracellular location of the hybrid bgal pro- fore travel freely between the nucleus and cytoplasm via
nuclear membrane pore, as the pore size is about 45 A˚,teins. In contrast to the cytoplasmic localization of wild-
type bgal protein expressed by an rVV (Fig. 4B), both the which allows most proteins with Mr less than 70 kDa to
move freely between the two compartments (Paine et al.,6L2NLS/bgal and 6L2DNABS/bgal proteins were ob-
served in the nucleus (Figs. 4E and 4F). Transport of 1975). Therefore, a sequence to keep the protein in the
nucleus could be necessary for L2 full function in thethe hybrid bgal protein to the nucleus is presumably
mediated by the L2 N- and C-terminal sequences be- nucleus. To confirm this hypothesis, HPV6L2 gene lack-
ing the information encoding for aa 286–306 was fusedcause their large size precludes passive diffusion. There-
fore, both the HPV6bL2 444RKRRKR449 and 5RARRRKR11 with a large portion of L1 protein lacking C-terminal NLS
sequence (D286–326/16L1) (Fig. 2). The resultant L1/L2sequences act as functional NLS which may contribute
to the translocation of L2 into the nucleus. hybrid protein is a large protein (with a predicted molecu-
lar weight of 89 kDa) which should be big enough to stayTo examine whether another sequence in the L2 pro-
tein participates in the protein nuclear transport and re- in the nucleus when it is transported into there. When
this hybrid protein was expressed by rVV (D286–326/tention, rVVs encoding the mutant L2 protein with dele-
tion of the N-terminal (D1–60) DNA binding sequence 16L1) in CV-1 cells, it was located in the nucleus either
using anti-L2 antiserum (Fig. 3(B3)) or anti HPV16L1 anti-or the C-terminal (D446–459) NLS or with deletion of
both the N-terminal and the C-terminal (D1–60/446–459) serum (Fig. 3(C3)). Because the 16L1 sequence (aa 191–
506), lacking a functional NLS, could not move to thewere constructed. When CV-1 cells were infected with
these rVV, all the mutated L2 proteins were observed in nucleus and accumulate there (Fig. 3(A3)), the nuclear
staining of L1/L2 hybrid protein indicated that the proteinthe nucleus (Fig. 3(C1, A2, B2)), although a weaker nu-
clear staining was observed in the mutant lacking both was transported to the nucleus by the N- and C-terminal
L2 sequences.N- and C-terminal ends (D1–60/446–459) (Fig. 3(B2)).
These results suggested that both the N- and C-terminal Analysis of the L2 sequences revealed that the se-
quence of aa 286–306 in HPV6B L2 protein is relativelyends contribute L2 nuclear transportation and the nu-
clear localization of native HPV6bL2 protein is not a prop- conserved among human papillomaviruses but is less
conserved in bovine papillomaviruses type 1 and type 2erty of the N- or C-terminal amino acid sequences alone.
To investigate which sequences within the HPV6b L2 (with exception of BPV4) (see Fig. 5).
protein promote L2 accumulation in the nucleus, we con-
structed a series of deletion mutations of L2 in which DISCUSSION
each member of the series had a 40 amino acid deletion
frame shifted 20 amino acids with respect to the adjacent Papillomaviruses are one of the finest examples of
genetic economy in nature. With enough genetic informa-members (Fig. 2). CV-1 cells were infected with rVV ex-
pressing each L2 mutant and the distribution of L2 was tion to code for only a few early proteins necessary for
DNA replication and gene transcription regulation, onlyestablished by immunofluorescence 48 hr after infection.
All mutants, except two lacking the amino acids 266 – two structural proteins are coded by the viral genome.
The L1 and L2 structural polypeptides of the papillomavi-326, were located in the nucleus (Fig. 2, upper panel) in
nucleus. Localization of L2 mutants D266–306 and ruses are synthesized in the host cell cytoplasm in a late
stage during permissive infection. Shortly after synthesis,D286–326, which lack a common 20 aa sequence (286–
306), was clearly cytoplasmic (Fig. 3(C2)). To determine they are transported into the cell nucleus (Zhou et al.,
1991b) where viral assembly takes place (Orth et al.,whether the aa 286–306 sequence could target an other-
wise cytoplasmic protein into the nucleus, the DNA se- 1977; Zhou et al., 1993). The translocation of L1 and L2
proteins are mediated by a sequence called NLS, whichquence encoding for aa 286–306 of HPV6b L2 protein
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FIG. 2. Schematic diagram of deletion mutants of HPV6bL2 proteins. The names of mutants were designated by the deleted amino acids. The
open boxes indicate the regions retained and solid boxes indicate the regions deleted. The subcellular localization of the various deletion mutants
of HPV6b L2 protein is indicated as N (nuclear), C (cytoplasmic), N/C (both nuclear and cytoplasmic), and N  C (dominant nuclear staining). In
the lower panel, the solid boxes represent the bgal gene (not to scale) and the gene fused with HPV6BL2 sequences represented by ovals (see
the upper panel for detailed sequences). The cellular distributions of the bgal fusion proteins are also indicated on the right.
is found in many viral nuclear proteins. It has been shown crystals were obtained for polyomavirus, a member of
the papovavirus family, and this data on structure mightthat the major antigen, L1, can itself assemble into empty
capsid-like particles (Kirnbauer et al., 1993; Hagensee et be comparable to that of papillomavirus. An electron den-
sity map of the inside of the polyoma virion displayed 72al., 1993; Volpers et al., 1994; Zhou et al., 1993), which
indicates that L2 is not absolutely required for capsid ‘‘prongs’’ of electron density extending from the core into
the cavities of the VP1 (equivalent to L1 of papillomavirus)structure assembly. The question therefore arises: what
are the functions of the minor capsid protein? The mech- pentamers. These prongs are believed to be the minor
protein VP3 or the C-terminal end of VP2 (equivalent toanism of viral DNA–histone complex encapsidation of
papillomavirus is not known at present. However, X-ray L2 protein of papillomaviruses), and it was suggested
that they may function to guide the assembly of the highlydiffraction data of empty capsids and complete virion
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FIG. 3. Localization of mutant L2 proteins by indirect immunofluorescence. CV-1 cells were infected with rVV expressing PV capsid proteins as
indicated below. At 48 hr postinfection, cells were fixed and analyzed for HPV capsid protein location by indirect immunofluorescence, using L2-
specific antiserum unless otherwise indicated. (A1) wild-type vaccinia virus; (A2) D1–60; (A3) 16L1 [anti L1 antiserum]; (B1) wild-type 6bL2; (B2)
D1 –60/446–459; (B3) D286–326/16L1; (C1) D446–459; (C2) D266–306; (C3) D286–326/16L1 [anti L1 antiserum]. For summary of immunofluores-
cence results please refer to Fig. 2.
ordered capsid on the nucleohistone core. Whether this L2 NLS and N-terminal DNA-binding domain were fused
to the protein, the hybrid protein exhibits a nuclear stain-is the case and by what mechanism it occurs in papillo-
mavirus needs further studies. ing pattern (Figs. 4E and 4F), suggesting the putative L2
NLS and DNA binding domain are functional in guidingPrevious studies showed that papillomavirus major
capsid protein L1 possesses a NLS which plays a vital nuclear transportation. Because L2 is a relatively small
protein with a predicted molecular weight of about 50role in the transport of the protein to the nucleus follow-
ing its synthesis in the cytoplasm. We have now extended kDa (Doorbar and Gallimore, 1987; Komly et al., 1986;
Tomita et al., 1987), this small protein could freely diffusethese studies and confirmed the nuclear targeting func-
tionality of the proposed C-terminal NLS and N-terminal into nucleus with subsequent retention in nucleus by
binding to nondiffusible nuclear elements. To demon-DNA binding domain in the minor capsid L2 protein.
However, this observation raises an intriguing question strate if the L2 protein could be concentrated in the nu-
cleus by such a mechanism, truncated L2 lacking theconcerning the mechanism of L2 nuclear accumulation,
as the typical NLS in its C-terminal end and DNA binding putative C-terminal NLS sequence (D446–459) or lack-
ing the DNA binding sequence (D1–60) were con-domain in its N-terminal end are not enough for L2 to
accumulate in the nucleus, as we demonstrated in this structed and the protein was expressed in CV-1 cells by
recombinant vaccinia viruses. The nuclear staining ofstudy. In the light of the hypothesis that nuclear entry
and nuclear accumulation of papillomavirus L2 proteins this truncated L2 suggested that parts of the L2 se-
quences, other than the N- and C-terminal sequences,are different phenomena encoded in different regions of
the L2 proteins, two approaches have been employed to are responsible for the L2 nuclear retention. We therefore
examined the L2 sequence in detail by using PCR-gener-address this issue. First, the predicted putative C-termi-
nal NLS sequence and N-terminal DNA binding domain ated deletion mutants. Our results suggest that the aa
286–306 (IASRRGLVRYSRIGQRGSMH) are responsiblewere fused with a large protein bgal which normally
locates in cytoplasm when expressed from recombinant for L2 nuclear accumulation and nuclear retention of the
L2 protein with such a nuclear accumulation sequencevectors as shown in Fig. 4. However, when the putative
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FIG. 4. Indirect immunofluorescence for bgal protein in CV-1 cells infected with various bgal rVV. CV-1 cells infected by rVV expressing (B) wild-
type bgal (bgal); (C, D) L2 with aa 286–306 deletion fused to bgal protein [6L2(286–306)/bgal]; and (E) bgal fused with aa 5–11 of HPV6BL2
(6L2DNABS/bgal); (F) 6L2 NLS sequence fused bgal (6L2NLS/bgal). Cells were fixed 48 hr after infection and stained with monoclonal antibody to
bgal (Gal-13) followed by FITC-conjugated anti-mouse IgG. The cells infected with wild-type vaccinia virus (A) was used as primary antibody control.
See Fig. 2 for summary of bgal fusion constructs and immunofluorescence results.
deleted could be achieved by fusing a large protein frag- some similarities with influenza nucleoprotein (Davey et
al., 1985) where the charged amino acids are separatedment to the L2 deletion mutant (D286–306/16L1) (Fig.
3(B3, C3)). by hydrophobic amino acids. For influenza virus proteins,
nuclear entry and nuclear accumulation are different phe-When the sequence of HPV6b L2 with apparent nu-
clear retention function was compared with the corre- nomena controlled by sequences in different regions of
the nucleoprotein (Davey et al., 1985). Proteolytic cleav-sponding sequence from other papillomavirus L2 pro-
teins, we found that this region was relatively conserved, age of nucleoplasmin results in two fragments, of which
only the smaller one retained the ability to migrate intosuggesting an important role of this sequence in L2 nu-
clear retention. This sequence of L2 protein also shows and accumulate in nuclei, while the large fragment re-
mains in whichever cellular compartment it was microin-
jected (Dingwall et al., 1982). Since the Mr of the larger
fragment was greater than 70,000, its inability to be trans-
ported across the nuclear envelope could indicate that
it has lost the NLS sequence necessary for active trans-
port, while the rapid nuclear accumulation of the small
fragment, which could diffuse freely across nuclear mem-
brane, suggests that it not only contains this transport
information (NLS) but also the information for nuclear
accumulation. It is not clear yet how the apparent nuclear
retention signal of the L2 protein anchors the molecule
in the nucleus. However, it is conceivable that this L2
sequence could bind to a nuclear protein and the resul-
tant complex is too big to diffuse into cytoplasm.
Two models are usually considered to explain the nu-
clear accumulation of certain proteins. The first one is
the free diffusion of small proteins into the nucleus with
the subsequent retention of the protein by binding to a
nuclear structure. The second one is the selective trans-
portation of large nuclear proteins across the nuclear
membrane via NLS sequence and accumulation in the
FIG. 5. Alignment of papillomavirus L2 proteins. The HPV6bL2 se- nucleus by its large size. Our results suggested that both
quence (aa 286–306) is shown on the top. The identical sequences
the selective nuclear transport (mediated by NLS andand similar ones are highlighted with * and ò, respectively. The corre-
DNA binding domain) and the nuclear structure bindingsponding sequences of BPV1 and BPV2 showing less conservative are
separated from HPVs by a gap. may play a role in the nuclear accumulation of papillo-
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L., Lowy, D. R., and Schiller, J. T. (1993). Efficient self-assembly ofmavirus L2 proteins, and these two activities are con-
human papillomavirus type 16 L1 and L1-L2 into virus-like particles.trolled by different regions of the protein. This is not the
J. Virol. 67, 6929–6936.
only viral protein using both mechanisms to accumulate Komly, C. A., Breitburd, F., Croissant, O., and Streeck, R. E. (1986). The
in the nucleus as the influenza virus nucleoprotein L2 open reading frame of human papillomavirus type 1a encodes a
minor structural protein carrying type-specific antigens. J. Virol. 60,seemed using both mechanisms for nuclear accumula-
813–816.tion (Davey et al., 1985). It may be advantageous having
Lanford, R. E., Kanda, P., and Kennedy, R. C. (1986). Induction of nuclearboth mechanism in papillomavirus L2 proteins for rapid
transport with a synthetic peptide homologous to the SV40 T antigen
nuclear transportation and accumulation. Like other vi- transport signal. Cell 46, 575–582.
ruses, papillomavirus may need such rapid nuclear trans- Lanford, R. E., and Butel, J. S. (1984). Construction and characterization
of an SV40 mutant defective in nuclear transport of T antigen. Cellport and accumulation process in their late life cycle for
37, 801–813.efficient infectious virion assembly. However, it cannot
Orth, G., Favre, M., and Croissant, O. (1977). Characterization of a newbe ruled out that interaction of the proposed retention
type of human papillomavirus that causes skin warts. J. Virol. 24,
sequences with nuclear components has other functions, 108–120.
rather than merely anchorage as suggested by our indi- Paine, P. L., Moore, L. C., and Horowitz, S. B. (1975). Nuclear envelope
permeability. Nature 254, 109–114.rect immunofluorescence assays.
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